Engineered Monkeypox Protein A29L Molecule (His Marker): A Scientific Tool
Engineered Monkeypox Protein A29L Molecule (His Marker): A Scientific Tool
Blog Article
This engineered Orthopoxvirus Protein A29 protein, containing a His marker, represents a significant laboratory tool for study of viral processes and potential biological targets. The His label facilitates for simple purification and detection using conventional immobilized chromatography, making it appropriate for a range of experiments including receptor binding tests, structure determination, and component synthesis experiments. In conclusion, this engineered protein offers a reproducible method to advance knowledge of Monkeypox pathogenesis.
Production and Characterization of Recombinant MPXV A29L Protein (His Tag)
The successful production of recombinant MPXV A29L molecule, tagged with a His tag, was realized using *E. coli* expression system. Preliminary procedures involved introducing the A29L DNA into a pet vector followed by introduction into competent *E. coli* cultures. Afterwards, improved growth settings were established to maximize yield. Purification of the His-tagged A29L molecule was conducted utilizing immobilized metal affinity separation. Characterization involved approaches such as SDS-PAGE, Western blotting, and mass spectrometry to verify identity and evaluate apparent weight and clarity. The isolated recombinant A29L polypeptide displayed appropriate mass and demonstrated the presence of the His label, supporting adequate expression and recovery.
Engineered Orthopoxvirus A29L Protein (His Tag|with a His-tag|His-tagged) for MPXV Research
The supply of recombinant MPXV A29L antigen (His Tag) represents a critical resource for advancing investigations into the mechanism of monkeypox disease. This protein facilitates straightforward detection and isolation through His chromatography, allowing for detailed analysis of its antigenic properties, interaction with immune factors, and role in viral infection. The His marker functions as a useful method for efficient production and cleansing, rendering it well suited for various spectrum of orthopoxvirus trials.
Maximizing Production of Produced MPXV A29L Molecule (His Tag | with a His Tag | tagged with His | featuring a His tag)
To achieve high yields of the recombinant MPXV A29L compound, numerous conditions require thorough fine-tuning . Primary attempts involved standard production in *E. coli*, however, this often resulted in reduced yields and significant inclusion formation formation. Thus, strategies such as altering the region strength, optimizing Recombinant MPXV A29L Protein(His Tag) the culture conditions , and employing supporting components to assist proper conformation were utilized . Besides, exploring other generation hosts , such as cells, is presently assessed to additionally maximize production and enhance compound quality .
Applications of Recombinant MPXV A29L Protein (His Tag) in Diagnostics
Recombinant MPXV A29L molecule (His label) demonstrates significant promise in developing accurate diagnostic methods for MPXV infection. Its utilization as a epitope in ELISA and rapid diagnostic platforms allows for specific interaction of antibodies from exposed individuals. The His tag aids purification and assessment of the modified A29L molecule, therefore boosting the total efficacy and selectivity of the identification protocol. Further study into its integration into combined detection panels remains a encouraging field of investigation.
Purified MPXV A29L Protein (His Tag) Stock and Characteristics
The engineered A29L antigen from Orthopoxvirus, featuring a His-tag for efficient isolation, is now available for laboratory use. This particular item is synthesized in bacteria and supplied as a powdered form, allowing for stable keeping. Typical characteristics include a size of approximately 140,000 Da, >90% homogeneity as determined by SDS-PAGE and a concentration of 1 mg/mL in a medium of PBS. Refer to the product guide for complete data regarding delivery conditions and advised handling procedures.
Report this page